Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through α2β1 integrin

Journal of Cell Biology

Volumn 166, Issue 1, 2004, Pages 97-109

  Bix, Gregory ^a   Fu, Jian ^a   Gonzalez, Eva M ^a   Macro, Laura ^a   Barker, Amy ^a   Campbell, Shelly ^a   Zutter, Mary M ^b   Santoro, Samuel A ^b   Kim, Jiyeun K ^c   Höök, Magnus ^c   Reed, Charles C ^a   Iozzo, Renato V ^a,d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Angiogenesis; Collagen; Endothelial cell; LG module; Perlecan proteoglycan

Indexed keywords

COLLAGEN TYPE 1; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOREPELLIN; FOCAL ADHESION KINASE; HEAT SHOCK PROTEIN 27; MITOGEN ACTIVATED PROTEIN KINASE P38; PERLECAN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; BASEMENT MEMBRANE; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; FOCAL ADHESION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SECOND MESSENGER; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ACTINS; ADENOVIRIDAE; CELL ADHESION; CELL LINE; CELLS, CULTURED; COLLAGEN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG COMBINATIONS; ENDOPLASMIC RETICULUM; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; HUMANS; INTEGRIN ALPHA2BETA1; LAMININ; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTEOGLYCANS; RECOMBINANT PROTEINS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 3142736457     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200401150     Document Type: Article

References (45)

1. Arikawa-Hirasawa, E., E. Watanabe, H. Takami, J.R. Hassell, and Y. Yamada. 1999. Perlecan is essential for cartilage and cephalic development, Nat. Genet. 23:354-358.
2. Arthur, W.T., L.A. Petch, and K. Burridge. 2000. Integrin engagement suppresses RhoA activity via a c-Src-dependent mechanism. Curr. Biol. 10:719-722.
3. Burridge, K., M. Chrzanowska-Wodnicka, and C. Zhong. 1997. Focal adhesion assembly. Trends Cell Biol. 7:342-347.
4. Costell, M., E. Gustafsson, A. Aszódi, M. Mörgelin, W. Bloch, E. Hunziker, K. Addicks, R. Timpl, and R. Fässler. 1999. Perlecan maintains the integrity of cartilage and some basement membranes. J. Cell Biol. 147:1109-1122.
5. Costell, M., R. Carmona, E. Gustafsson, M. González-Iriarte, R. Fässler, and R. Munoz-Chápuli. 2002. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ. Res. 91:158-164.
6. Dickeson, S.K., J.J. Walsh, and S.A. Santoro. 1997. Contribution of the I and EF hand domains to the divalent cation-dependent collagen binding activity of the α2β1 integrin. J. Biol. Chem. 272:7661-7668.
7. Dong, J.-M., T. Leung, E. Manser, and L. Lim. 1998. cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKα. J. Biol. Chem. 273:22554-22562.
8. Emsley, J., C.G. Knight, R.W. Farndale, M.J. Barnes, and R.C. Liddington. 2000. Structural basis of collagen recognition by integrin α2β1. Cell 101:47-56.
9. Folkman, J. 2002. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29:15-18.
10. Giancotti, F.G., and E. Ruoslahti. 1999. Integrin signaling. Science. 285:1028-1032.
11. Guay, J., H. Lambert, G. Gingras-Breton, J.N. Lavoie, J. Huot, and J. Landry. 1997. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J. Cell Sci: 110:357-368.
12. Hanke, J.H., J.P. Gardner, R.L. Dow, P.S. Changelian, W.H. Brissette, E.J. Weringer, B.A. Pollok, and P.A. Connelly. 1996. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271:695-701.
13. Huot, J., F. Houle, F. Marceau, and J. Landry. 1997. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ. Res. 80:383-392.
14. Ilic, D., B. Kovacic, S. McDonagh, F. Jin, C. Baumbusch, D.G. Gatdner, and C.H. Damsky. 2003. Focal adhesion kinase is required for blood vessel morphogenesis. Circ. Res. 92:300-307.
15. Iozzo, R.V. 1998. Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 67:609-652.
16. Iozzo, R.V., and J.D. San Antonio. 2001. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J. Clin. Invest. 108:349-355.
17. Ivaska, J., H. Reunanen, J. Westermarck, L. Koivisto, V.-M. Kähäri, and J. Heino. 1999. Integrin α2β1 mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the α2 cytoplasmic tail. J. Cell Biol. 147:401-415.
18. Jiang, Y., C. Chen, Z. Li, W. Guo, J.A. Gegner, S. Lin, and J. Han. 1996. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J. Biol. Chem. 271:17920-17926.
19. 1 and protein kinase A. J. Biol. Chem. 275:33920-33928.
20. Kjoller, L., and A. Hall. 1999. Signaling to Rho GTPases. Exp. Cell Res. 253:166-179.
21. Klekokta, P.A., S.A. Santoro, and M.M. Zutter. 2001. α2 integrin subunit cytoplasmic domain-dependent cellular migration requires p38 MAPK. J. Biol. Chem. 276:9503-9511.
22. Knight, C.G., L.F. Morton, A.R. Peachey, D.S. Tuckerwell, R.W. Farndale, and M.J. Barnes. 2000. The collagen-binding A-domains of integrins α1β1 and α2β1 recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J. Biol. Chem. 275:35-40.
23. Lang, P., F. Gesbert, M. Delespine-Carmagnar, R. Stancou, M. Pouchelet, and J. Bertoglio. 1996. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J. 15:510-519.
24. Mongiat, M., S. Sweeney, J.D. San Antonio, J. Fu, and R.V. Iozzo. 2003. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem. 278:4238-4249.
25. Mudgett, J.S., J. Ding, L. Guh-Siesel, N.A. Chartain, L. Yang, S. Gopal, and M.M. Shen. 2000. Essential role for p38α mitogen-activated protein kinase in placental angiogenesis. Proc. Natl. Acad. Sci. USA. 97:10454-10459.
26. Nugent, M.A., H.M. Nugent, R.V. Iozzo, K. Sanchack, and E.R. Edelman. 2000. Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia. Proc. Natl. Acad. Sci. USA. 97:6722-6727.
27. Rehn, M., T. Veikkola, E. Kukk-Valdre, H. Nakamura, M. Ilmonen, C.R. Lombardo, T. Pihlajaniemi, K. Alitalo, and K. Vuori. 2001. Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. USA. 98:1024-1029.
28. Ren, X.-D., W.B. Kiosses, and M.A. Schwartz. 1999. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18:578-585.
29. Rousseau, S., F. Houle, J. Landry, and J. Huot. 1997. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene. 15:2169-2177.
30. Rousseau, S., F. Houle, H. Kotanides, L. Witte, J. Waltenberger, J. Landry, and J. Huot. 2000. Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase. J. Biol. Chem. 275:10661-10672.
31. Sasaki, T., H. Larsson, J. Kreuger, M. Salmivirta, L. Claesson-Welsh, U. Lindahl, E. Hohenester, and R. Timpl. 1999. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J. 18:6240-6248.
32. Schoenwaelder, S.M., and K. Burridge. 1999. Bidirectional signaling between the cytoskeleton and integrins. Curr. Opin. Cell Biol. 11:274-286.
33. Senger, D.R., C.A. Petruzzi, M. Streit, V.E. Koteliansky, A.R. de Fougerolles, and M. Detmar. 2002. The α1β1 and α2β1 integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am. J. Pathol. 160:195-204.
34. Sieg, D.J., C.R. Hauck, D. Llic, C.K. Kingbeil, E. Schaefer, C.H. Damsky, and D.D. Schlaepfer. 2000. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2:249-257.
35. Sudhakar, A., H. Sugimoto, C. Yang, J. Lively, M. Zeisberg, and R. Kalluri. 2003. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins. Proc. Natl. Acad. Sci. USA. 100:4766-4771.
36. Sweeney, S.M., G. DiLullo, S.J. Slater, J. Martinez, R.V. Iozzo, J.L. Lauer-Fields, G.B. Fields, and J.D. San Antonio. 2003. Angiogenesis in collagen I requires α2β1 ligation of a GFP*GER sequence and possibly p38 MAPK activation and focal adhesion disassembly. J. Biol. Chem. 278:30516-30524.
37. Talts, J.F., Z. Andac, W. Göhring, A. Brancaccio, and R. Timpl. 1999. Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins. EMBO J. 18:863-870.
38. Uehata, M., T. Ishizaki, H. Satoh, T. Ono, T. Kawahara, T. Morishita, H. Tamakawa, K. Yamagami, J. Inui, M. Maekawa, et al. 1997. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 389:990-994.
39. Walker, H.A., J.M. Whitelock, P.J. Garl, R.A. Nemenoff, K.R. Stenmark, and W.C.M. Weiser-Evans. 2003. Perlecan up-regulation of FRNK suppresses smooth muscle cell proliferation via inhibition of FAK signaling. Mol. Biol. Cell. 14:1941-1952.
40. Wang, X.-Q., F.P. Lindberg, and W.A. Frazier. 1999. Integrin-associated protein stimulates α2β1-dependent chemotaxis via Gi-mediated inhibition of adenylate cyclase and extracellular-regulated kinases. J. Cell Biol. 147:389-399.
41. Whelan, M.C., and D.R. Senger. 2003. Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J. Biol. Chem. 278:327-334.
42. 1 and caveolin-1, and activates src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res 62:5580-5589.
43. Wickström, S.A., K. Alitalo, and J. Keski-Oja. 2003. Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity. J. Biol. Chem. 278:37895-37901.
44. Xu, Y., S. Gurusiddappa, R.L. Rich, R.T. Owens, D.R. Keene, R. Mayne, A. Höök, and M. Höök. 2000. Multiple binding sites in collagen type I for the integrins α1β1 and α2β1. J. Biol. Chem. 275:38981-38989.
45. Zutter, M.M., S.A. Santoro, J.E. Wu, T. Wakatsuki, S.K. Dickeson, and E.L. Elson. 1999. Collagen receptor control of epithelial morphogenesis and cell cycle progression. Am. J. Pathol. 155:927-940.